Solana Company (formerly Helius Medical Technologies) Overview
Pro stress-test →Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. The company has announced its continued acquisition of Solana tokens as part of its digital asset treasury strategy, now holding over 2.2 million SOL. The company represents a hybrid model combining legacy medical device operations with an aggressive blockchain asset accumulation strategy.
Strategic Profile
Pro stress-test →As an independent treasury company, HSDT's mission is to support the growth and security of tokenized networks by serving as a long-term holder of SOL, in addition to continuing the development of its neurotech and medical device operations. The company's combined Solana holdings and cash holdings exceed $525 million of value. The company leverages public capital markets access to accumulate yield-generating crypto assets while maintaining a portfolio of neurotech medical devices for neurological conditions.
Competitive Landscape
Pro stress-test →The company positions itself similarly to MSTR (MicroStrategy) and BMNR (Bit Digital) in the crypto treasury space. In medical devices, PoNS competes in neuromodulation for neurological deficits but operates as a minor revenue line. The primary competitive dynamic is against other SOL-accumulation vehicles and treasury strategies rather than traditional medtech companies.
Industry Context
Solana Company (formerly Helius Medical Technologies) operates in Digital Asset Treasury / Crypto Accumulation (primary); Medical Device - Neurotech (legacy).
Key facts
Founded: 2014 · Headquarters: Newtown, Pennsylvania, US · Revenue: $0.7M (Q3 2025, crypto inclusive)